About the Session

In our latest episode, we're excited to host Dr. Geetha Manjunath, founder and CEO of Niramai Health Analytix. With over 25 years of experience in AI and a PhD from IISc, Dr. Geetha has led Niramai to develop a breakthrough, non-invasive, radiation-free test for early-stage breast cancer detection. 🌟

During our discussion, we explore:

1️⃣ The story behind Niramai and its AI-driven solution for early breast cancer detection
2️⃣ Overcoming challenges in healthcare innovation
3️⃣ The future of non-invasive screening technology
4️⃣ An exciting Rapid-Fire

Tune in now to learn more about the future of cancer screening and how Dr. Geetha’s work is making a significant impact in healthcare! 🎧

About the Speaker

Dr. Geetha Manjunath, who is currently the Founder & CEO of Niramai Analytix. She has led the company to develop a breakthrough artificial-intelligence-based test for detecting early stage breast cancer in a non-invasive, radiation-free manner.

She is a Computer Scientist with a PhD from Indian Institute of Science and management education from Kellogg’s School of Management. She has over 25 years of experience and has led multiple AI projects at Xerox Research and Hewlett Packard Labs before starting Niramai.

Dr. Geetha has received many international and national recognition for her innovations and entrepreneurial work, including CSI Gold Medal, BIRAC WinER Award 2018 and is also on the Forbes List of Top 20 Self-Made Women 2020. She was awarded the Accenture Vahini Innovator of the Year Award from Economic Times and Women Entrepreneur of the Year 2020 by BioSpectrum India.